F692-0205 Screening compound: N~2~-[3-(4-cyclohexylpiperazino)propyl]-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide

F692-0205 Screening compound: N~2~-[3-(4-cyclohexylpiperazino)propyl]-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide
F692-0205 Screening compound: N~2~-[3-(4-cyclohexylpiperazino)propyl]-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F692-0205
N~2~-[3-(4-cyclohexylpiperazino)propyl]-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F692-0205

Molecular Formula

C24H31N5O2S (C24 H31 N5 O2 S)

Compound Name

N~2~-[3-(4-cyclohexylpiperazino)propyl]-4-oxo-4H-[1,3]thiazino[3,2-a][1,3]benzimidazole-2-carboxamide

IUPAC name

N-[3-(4-cyclohexylpiperazin-1-yl)propyl]-13-oxo-10-thia-18-diazatricyclo[7.4.0.0^{27}]trideca-246811-pentaene-11-carboxamide

SMILES

O=C(C(Sc1nc(cccc2)c2n11)=CC1=O)NCCCN(CC1)CCN1C1CCCCC1

InChI

InChI=1S/C24H31N5O2S/c30-22-17-21(32-24-26-19-9-4-5-10-20(19)29(22)24)23(31)25-11-6-12-27-13-15-28(16-14-27)18-7-2-1-3-8-18/h4-5,9-10,17-18H,1-3,6-8,11-16H2,(H,25,31)

InChI Key

NWYXRVCYDFVGLP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14963744

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.620

Distribution Coefficient, logD

1.710

Water Solubility, LogSw

-2.91

Polar Surface Area

55.967

Acid Dissociation Constant (pKa)

14.28

Base Dissociation Constant (pKb)

8.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

F692-0205 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F692-0205 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F692-0205?
Check Price and Availability of F692-0205, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F692-0205 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F692-0205
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F692-0205
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F692-0205 available by request